Dorte Vendelbo Jensen
About
Dorte Vendelbo Jensen is a scholar working on Rheumatology, Public Health, Environmental and Occupational Health and Infectious Diseases.
According to data from OpenAlex, Dorte Vendelbo Jensen has authored 41 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Rheumatology, 8 papers in Public Health, Environmental and Occupational Health and 5 papers in Infectious Diseases. Recurrent topics in Dorte Vendelbo Jensen's work include Rheumatoid Arthritis Research and Therapies (21 papers), Systemic Lupus Erythematosus Research (11 papers) and Pregnancy-related medical research (7 papers). Dorte Vendelbo Jensen is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (21 papers), Systemic Lupus Erythematosus Research (11 papers) and Pregnancy-related medical research (7 papers). Dorte Vendelbo Jensen collaborates with scholars based in Denmark, United States and Norway. Dorte Vendelbo Jensen's co-authors include Merete Lund Hetland, Annette Hansen, Hanne Lindegaard, Mikkel Østergaard, Ulrik Tarp, Annette Schlemmer, Louise Linde, Charlotte Wilken‐Jensen, Elisabeth Clare Larsen and Lene Dreyer and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Arthritis Research & Therapy.
In The Last Decade
Dorte Vendelbo Jensen
40 papers receiving 1.6k citations
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Dorte Vendelbo Jensen Denmark | 17 | 983 | 410 | 371 | 348 | 252 | 41 | 1.6k | ||
| K. Mikkelsen Norway | 25 | 1.5k 1.5× | 915 2.2× | 538 1.5× | 254 0.7× | 163 0.6× | 56 | 2.1k | ||
| Gregory F. Keenan United States | 16 | 609 0.6× | 509 1.2× | 358 1.0× | 333 1.0× | 508 2.0× | 27 | 1.8k | ||
| Katinka Albrecht Germany | 24 | 1.3k 1.3× | 241 0.6× | 459 1.2× | 68 0.2× | 214 0.8× | 105 | 1.8k | ||
| Adeline Ruyssen‐Witrand France | 24 | 1.5k 1.5× | 567 1.4× | 555 1.5× | 63 0.2× | 277 1.1× | 109 | 2.2k | ||
| Dianne Mosher Canada | 21 | 745 0.8× | 290 0.7× | 278 0.7× | 91 0.3× | 169 0.7× | 71 | 1.3k | ||
| Jessica Berman United States | 15 | 1.0k 1.0× | 960 2.3× | 547 1.5× | 215 0.6× | 135 0.5× | 31 | 2.2k | ||
| Victoria Navarro‐Compán Spain | 25 | 2.0k 2.1× | 1.1k 2.7× | 693 1.9× | 132 0.4× | 121 0.5× | 198 | 2.5k | ||
| Devy Zisman Israel | 26 | 888 0.9× | 738 1.8× | 359 1.0× | 86 0.2× | 172 0.7× | 95 | 1.7k | ||
| Emmanuelle Dernis France | 20 | 891 0.9× | 345 0.8× | 336 0.9× | 74 0.2× | 165 0.7× | 72 | 1.3k | ||
| Carolyn Neville Canada | 20 | 961 1.0× | 362 0.9× | 311 0.8× | 80 0.2× | 92 0.4× | 40 | 1.3k |
Countries citing papers authored by Dorte Vendelbo Jensen
Since
Specialization
Citations
This map shows the geographic impact of Dorte Vendelbo Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dorte Vendelbo Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dorte Vendelbo Jensen more than expected).
Fields of papers citing papers by Dorte Vendelbo Jensen
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Dorte Vendelbo Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dorte Vendelbo Jensen. The network helps show where Dorte Vendelbo Jensen may publish in the future.
Co-authorship network of co-authors of Dorte Vendelbo Jensen
This figure shows the co-authorship network connecting the top 25 collaborators of Dorte Vendelbo Jensen. A scholar is included among the top collaborators of Dorte Vendelbo Jensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dorte Vendelbo Jensen. Dorte Vendelbo Jensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Brinth, Louise, Annette Hansen, Dorte Vendelbo Jensen, et al.. (2023). Diagnostic Value of Composite and Simplified FDG-PET/CT Scores in Polymyalgia Rheumatica and the Influence of Recent Glucocorticoid Treatment—A Retrospective Diagnostic Cohort Study. Diagnostics. 13(3). 514–514.
2.
Glintborg, Bente, Dorte Vendelbo Jensen, Lene Terslev, et al.. (2022). Long-term Behavioral Changes During the COVID-19 Pandemic and Impact of Vaccination in Patients With Inflammatory Rheumatic Diseases. The Journal of Rheumatology. 49(10). 1163–1172.
3.
Ørnbjerg, Lykke Midtbøll, Elisabeth Svensson, Lene Dreyer, et al.. (2022). Conversion of the MDHAQ to the HAQ score: a simple algorithm developed and validated in a cohort of 13 391 real-world patients. Lara D. Veeken. 61(10). 3919–3929.
4.
Glintborg, Bente, Dorte Vendelbo Jensen, Lene Terslev, et al.. (2021). Anxiety and concerns related to the work situation during the second wave of the COVID-19 pandemic in >5000 patients with inflammatory rheumatic disease followed in the DANBIO registry. RMD Open. 7(2). e001649–e001649.
5.
Glintborg, Bente, Dorte Vendelbo Jensen, Lene Terslev, et al.. (2021). Self-protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic: results and predictors in more than 12 000 patients with inflammatory rheumatic diseases followed in the Danish DANBIO registry. RMD Open. 7(1). e001505–e001505.
6.
Georgiadis, Stylianos, Anne Gitte Loft, Oliver Hendricks, et al.. (2021). Comparative effectiveness of two adalimumab biosimilars in 1318 real-world patients with inflammatory rheumatic disease mandated to switch from originator adalimumab: nationwide observational study emulating a randomised clinical trial. Annals of the Rheumatic Diseases. 80(11). 1400–1409.
7.
Kopp, Tine Iskov, Bénédicte Delcoigne, Elizabeth V. Arkema, et al.. (2020). Risk of neuroinflammatory events in arthritis patients treated with tumour necrosis factor alpha inhibitors: a collaborative population-based cohort study from Denmark and Sweden. Annals of the Rheumatic Diseases. 79(5). 566–572.
8.
Dreyer, Lene, Tine Iskov Kopp, Rikke Kart Jacobsen, et al.. (2018). Risk of Neurological Adverse Events during Tumour Necrosis FactorInhibitor Treatment for Arthritis::A Population-Based Cohort Study from Danbio and the Danish National Patient Registry. VBN Forskningsportal (Aalborg Universitet).
9.
Ibfelt, Else Helene, Dorte Vendelbo Jensen, & Merete Lund Hetland. (2016). The Danish nationwide clinical register for patients with rheumatoid arthritis: DANBIO. Clinical Epidemiology. Volume 8. 737–742.
10.
Ørnbjerg, Lykke Midtbøll, Mikkel Østergaard, Pernille Bøyesen, et al.. (2014). Which Factors Influence Radiographic Progression During Treatment with Tumor Necrosis Factor Inhibitors in Clinical Practice? Results from 930 Patients with Rheumatoid Arthritis in the Nationwide Danish DANBIO Registry. The Journal of Rheumatology. 41(12). 2352–2360.
11.
Ørnbjerg, Lykke Midtbøll, Mikkel Østergaard, Pernille Bøyesen, et al.. (2012). Impact of tumour necrosis factor inhibitor treatment on radiographic progression in rheumatoid arthritis patients in clinical practice: results from the nationwide Danish DANBIO registry. Annals of the Rheumatic Diseases. 72(1). 57–63.
12.
Glintborg, Bente, Mikkel Østergaard, Niels Steen Krogh, et al.. (2012). Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients after switching tumour necrosis factor α inhibitor therapy: results from the Danish nationwide DANBIO registry. Annals of the Rheumatic Diseases. 72(7). 1149–1155.
13.
Dreyer, Lene, Lene Mellemkjær, Philip Bennett, et al.. (2012). Incidences of overall and site specific cancers in TNFα inhibitor treated patients with rheumatoid arthritis and other arthritides – a follow-up study from the DANBIO Registry. Annals of the Rheumatic Diseases. 72(1). 79–82.
14.
Andersen, Vibeke, Dorte Vendelbo Jensen, Mette Østergaard, et al.. (2009). The multidrug resistance 1 (MDR1) gene polymorphism G-rs3789243-A is not associated with disease susceptibility in Norwegian patients with colorectal adenoma and colorectal cancer; a case control study. BMC Medical Genetics. 10(1). 18–18.
15.
Linde, Louise, Jan Sørensen, Mikkel Østergaard, et al.. (2009). What Factors Influence the Health Status of Patients with Rheumatoid Arthritis Measured by the SF-12v2 Health Survey and the Health Assessment Questionnaire?. The Journal of Rheumatology. 36(10). 2183–2189.
16.
Søborg, Bolette, Morten Rühwald, Merete Lund Hetland, et al.. (2009). Comparison of Screening Procedures for Mycobacterium tuberculosis Infection Among Patients with Inflammatory Diseases. The Journal of Rheumatology. 36(9). 1876–1884.
17.
Hansen, Annette, Dorte Vendelbo Jensen, Elisabeth Clare Larsen, et al.. (2005). Postpartum pelvic pain - the ‘pelvic joint syndrome’: a follow-up study with special reference to diagnostic methods. Acta Obstetricia Et Gynecologica Scandinavica. 84(2). 170–176.
18.
Larsen, Elisabeth Clare, Charlotte Wilken‐Jensen, Annette Hansen, et al.. (1999). Symptom‐giving pelvic girdle relaxation in pregnancy, I: Prevalence and risk factors. Acta Obstetricia Et Gynecologica Scandinavica. 78(2). 105–110.
19.
Hansen, Annette, Dorte Vendelbo Jensen, Merete Wormslev, et al.. (1999). Symptom‐giving pelvic girdle relaxation in pregnancy, II: Symptoms and clinical signs. Acta Obstetricia Et Gynecologica Scandinavica. 78(2). 111–115.
20.
Hansen, Annette, Dorte Vendelbo Jensen, Elisabeth Clare Larsen, Charlotte Wilken‐Jensen, & Lone Kjeld Petersen. (1996). Relaxin is not related to symptom‐giving pelvic girdle relaxation in pregnant women. Acta Obstetricia Et Gynecologica Scandinavica. 75(3). 245–249.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by K. Mikkelsen Breakdown of academic impact, for papers by Gregory F. Keenan Breakdown of academic impact, for papers by Katinka Albrecht Breakdown of academic impact, for papers by Adeline Ruyssen‐Witrand Breakdown of academic impact, for papers by Dianne Mosher Breakdown of academic impact, for papers by Jessica Berman Breakdown of academic impact, for papers by Victoria Navarro‐Compán Breakdown of academic impact, for papers by Devy Zisman Breakdown of academic impact, for papers by Emmanuelle Dernis Breakdown of academic impact, for papers by Carolyn Neville